"Cure Leukaemia’s funding of the UK Trials Acceleration Programme (TAP) is a game-changer and increases the access for blood cancer patients to potentially transformative new therapies."
Sir John Bell
- Home
- Fundraising
-
About Us
- Founders
- News
- The Trials Acceleration Programme (TAP)
- Our TAP Centres and Nurses
- Where Your Money Goes
- What Our Nurses Do
- Professor Charlie Craddock CBE
- Corporate Partnerships
- Our Trustees and Patrons
- Deutsche Bank Partnership
- The Cure Leukaemia Team
- Publications
- Privacy Policy
- Join The #CLFamily
- Sustainability Policy
- About Leukaemia
- Patient Stories
- The Tour 21
- London 2 Paris 2021
Menu
Fundraising
About Us
About Leukaemia
Patient Stories
The Tour 21
London 2 Paris 2021
- Founders
- News
- The Trials Acceleration Programme (TAP)
- Our TAP Centres and Nurses
- Where Your Money Goes
- What Our Nurses Do
- Professor Charlie Craddock CBE
- Corporate Partnerships
- Our Trustees and Patrons
- Deutsche Bank Partnership
- The Impact Of One Day
- A Message From Cure Leukaemia co-founder Professor Charlie Craddock CBE
- Deutsche Bank's £2m Positive Impact
- Patient Stories
- Working Together - Events To Excite And Engage
- Let's Get Social
- Well-Known Figures Show Their Support For Cure Leukaemia
- The Cure Leukaemia Team
- Publications
- Privacy Policy
- Join The #CLFamily
- Sustainability Policy
Reaction to Chancellor's announcement
9th April 2020
Chief Executive, James McLaughlin offers his thoughts after the announcement from Chancellor,
Rishi Sunak regarding a £750m package to aid charities in the wake of the COVID-19 pandemic.
